2026 is gearing up to be another milestone year in diabetes innovations. From continuous ketone monitoring to once-weekly insulin and new GLP-1 combinations like the “Triple G”, it should be an exciting year! Here are the biggest advancements coming down the pike.
read more →
Over the last two years, there’s been conflicting information in the news about GLP-1 medications and mental health. Some reports raised concerns about possible mood-related side effects, but others shared mental health benefits and broader therapeutic potential. Here’s what we know so far – and what still needs further research.
read more →
Ozempic and Mounjaro are similar in many ways, but there’s one key difference between the two. Learn how these blockbuster type 2 diabetes medications are changing the landscape of diabetes management, and find out why they aren’t yet approved for use in type 1.
read more →
Recent shortages of medications like Ozempic and Mounjaro have caused an influx of imitation drugs around the world. The FDA and World Health Organization have issued warnings about the safety risks of taking these counterfeit products because they can contain questionable ingredients that can cause series harm. Dr. Edelman explains how to know if the medication you’re taking is authentic and what to look out for in fake products.
read more →
Registered Dietitian Janice Baker shares how people with diabetes can prevent muscle loss and optimize muscle strength if they are working on losing weight.
read more →
If You’re a Member of the Healthcare Community–You Can’t Miss Our Next CME!
Earn easy CME credits and improve patient outcomes—all at your own pace.
